The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 03, 2018
Filed:
Mar. 08, 2016
Applicant:
The University of Utah Research Foundation, Salt Lake City, UT (US);
Inventors:
Joseph Cappello, San Diego, CA (US);
Hamidreza Ghandehari, Salt Lake City, UT (US);
Azadeh Poursaid, Salt Lake City, UT (US);
Assignee:
University of Utah Research Foundation, Salt Lake City, UT (US);
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/78 (2006.01); A61K 38/39 (2006.01); A61K 47/42 (2017.01); A61K 45/06 (2006.01); A61K 9/00 (2006.01); C07K 14/435 (2006.01); A61K 38/17 (2006.01);
U.S. Cl.
CPC ...
C07K 14/78 (2013.01); A61K 9/0019 (2013.01); A61K 9/0024 (2013.01); A61K 38/1767 (2013.01); A61K 38/39 (2013.01); A61K 45/06 (2013.01); A61K 47/42 (2013.01); C07K 14/43586 (2013.01);
Abstract
A chemoembolic agent is disclosed that includes an injectable, recombinantly synthesized silk-elastin like protein copolymer and one or more chemotherapeutic agents. Upon injection, the chemoembolic agent blocks the tumor vasculature, including the capillary bed, and may optionally release chemotherapeutic agents. The chemoembolic agent may be used to treat cancer, including hepatocellular carcinoma.